342.35  -3.93 (-1.13%)		10-24 16:00
Open: 347.01 High: 348.87 Volume: 1,318,281		Pre. Close: 346.28 Low: 340.04 Market Cap: 76,084(M)

Short term
Mid term
Targets	6-month :	426.16	1-year :	497.76
Resists	First :	364.86	Second :	426.16
Pivot price	351.14
Supports	First :	331.57	Second :	311
MAs	MA(5) :	347.53	MA(20) :	346.66
	MA(100) :	330.47	MA(250) :	373.79
MACD	MACD :	6.2	Signal :	8.2
%K %D	K(14,3) :	35.7	D(3) :	48.9
RSI	RSI(14): 52.2
52-week	High :	458.75	Low :	273.7

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ELV ] has closed above bottom band by 6.6%. Bollinger Bands are 56.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	349.31 - 351.01	351.01 - 352.68
Low:	335.04 - 337.17	337.17 - 339.27
Close:	338.4 - 341.78	341.78 - 345.11

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Fri, 24 Oct 2025
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery (NYSE:ELV) - Seeking Alpha

Wed, 22 Oct 2025
Elevance Health (ELV) Announces Fiscal Q3 2025 Results - Insider Monkey

Wed, 22 Oct 2025
Elevance Health (ELV) Announces Fiscal Q3 2025 Results - Yahoo Finance

Wed, 22 Oct 2025
Barclays Maintains Elevance Health (ELV) Overweight Recommendation - Nasdaq

Wed, 22 Oct 2025
Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus

Tue, 21 Oct 2025
Elevance Health: Q3 Earnings Snapshot - Greenwich Time

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	225 (M)
Shares Float	225 (M)
Held by Insiders	0.1 (%)
Held by Institutions	93 (%)
Shares Short	3,200 (K)
Shares Short P.Month	2,700 (K)

EPS	23.55
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	194.46
Profit Margin	2.8 %
Operating Margin	5.2 %
Return on Assets (ttm)	4.6 %
Return on Equity (ttm)	12.4 %
Qtrly Rev. Growth	14 %
Gross Profit (p.s.)	225.55
Sales Per Share	840.43
EBITDA (p.s.)	42.14
Qtrly Earnings Growth	-21.7 %
Operating Cash Flow	6,450 (M)
Levered Free Cash Flow	12,050 (M)

PE Ratio	14.53
PEG Ratio	0
Price to Book value	1.76
Price to Sales	0.4
Price to Cash Flow	11.95

Dividend	1.71
Forward Dividend	0
Dividend Yield	0.4%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.